Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Nemolizumab by Galderma for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
Nemolizumab is under clinical development by Galderma and currently in Pre-Registration for Atopic Dermatitis (Atopic Eczema). According to GlobalData, Pre-Registration...
Data Insights
Nemolizumab by Galderma for Chronic Kidney Disease (Chronic Renal Failure): Likelihood of Approval
Nemolizumab is under clinical development by Galderma and currently in Phase III for Chronic Kidney Disease (Chronic Renal Failure). According...